CA Stock MarketDetailed Quotes

MDCX Medicus Pharma Ltd

Watchlist
  • 3.950
  • 0.0000.00%
15min DelayMarket Closed Dec 12 16:00 ET
46.68MMarket Cap-3.32P/E (TTM)

Medicus Pharma Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1,225.21%3.01M
1,480.74%4.04M
342.82%1.78M
207.85%3.01M
1,079.95%2.13M
-16.42%226.81K
-1.27%255.69K
50.30%402.53K
-32.12%978.42K
180.27K
Selling and administrative expenses
1,081.17%2.2M
1,329.78%2.95M
331.91%1.44M
748.87%2.82M
2,208.60%2.09M
126.77%186.42K
182.34%206.12K
286.90%333.42K
28.69%332.03K
--90.64K
-General and administrative expense
1,081.17%2.2M
1,329.78%2.95M
331.91%1.44M
748.87%2.82M
2,208.60%2.09M
126.77%186.42K
182.34%206.12K
286.90%333.42K
28.69%332.03K
--90.64K
Research and development costs
1,824.78%777.51K
2,055.88%1.07M
357.78%316.39K
-70.05%193.58K
-61.51%34.5K
-78.64%40.4K
-73.34%49.58K
-61.95%69.11K
-45.38%646.38K
--89.63K
Depreciation amortization depletion
--26.32K
--26.04K
--26.04K
----
----
--0
--0
--0
----
----
-Depreciation and amortization
--26.32K
--26.04K
--26.04K
----
----
--0
--0
--0
----
----
Operating profit
-1,225.21%-3.01M
-1,480.74%-4.04M
-342.82%-1.78M
-207.85%-3.01M
-1,079.95%-2.13M
16.42%-226.81K
1.27%-255.69K
-50.30%-402.53K
32.12%-978.42K
-180.27K
Net non-operating interest income (expenses)
115.18%46.53K
77.12%-88.26K
97.31%-9.01K
-6.21%-1.17M
-34.31%-431.59K
-9.30%-306.48K
-41.64%-385.79K
-46.63%-334.56K
-59.55%-1.1M
-321.33K
Non-operating interest income
--55.51K
----
----
----
----
--0
----
----
----
----
Non-operating interest expense
-97.07%8.98K
-63.52%88.26K
-95.28%9.01K
40.29%739.1K
--0
124.45%306.48K
88.26%241.92K
126.20%190.7K
356.50%526.83K
--177.47K
Total other finance cost
----
----
----
-25.00%431.59K
----
----
-0.00%143.86K
0.00%143.86K
0.00%575.45K
--143.86K
Other net income (expenses)
-769.93%-2.6M
-261.22%-289.21K
-1,582.18%-2.43M
1,301.82%152.81K
339.09%253.17K
404.44%388.31K
179.39K
Gain on sale of security
----
----
----
427.53%670.1K
204.37%431.59K
-26.66%120.26K
1,301.82%152.81K
339.09%253.17K
-365.78%-204.6K
---413.51K
Special income (charges)
----
----
----
--0
----
----
----
----
--592.9K
----
-Less:Other special charges
----
----
----
----
----
----
----
----
---592.9K
----
Other non-operating income (expenses)
----
----
----
---3.27M
---720.8K
---2.55M
----
----
----
----
Income before tax
0.15%-2.96M
-745.18%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
Income tax
Earnings from equity interest net of tax
Net income
0.15%-2.96M
-745.18%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
Net income continuous operations
0.15%-2.96M
-745.18%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
---322.21K
Noncontrolling interests
Net income attributable to the company
0.15%-2.96M
-745.19%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
0.15%-2.96M
-745.19%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
Diluted earnings per share
78.91%-0.31
-723.55%-0.5
-265.92%-0.22
-121.27%-1.94
-121.00%-0.3526
-665.54%-1.47
10.18%-0.0607
72.30%-0.0601
-243.36%-0.8768
-0.1596
Basic earnings per share
78.91%-0.31
-723.55%-0.5
-265.92%-0.22
-121.27%-1.94
-121.00%-0.3526
-665.54%-1.47
10.18%-0.0607
72.30%-0.0601
-243.36%-0.8768
-0.1596
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unaudited
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1,225.21%3.01M1,480.74%4.04M342.82%1.78M207.85%3.01M1,079.95%2.13M-16.42%226.81K-1.27%255.69K50.30%402.53K-32.12%978.42K180.27K
Selling and administrative expenses 1,081.17%2.2M1,329.78%2.95M331.91%1.44M748.87%2.82M2,208.60%2.09M126.77%186.42K182.34%206.12K286.90%333.42K28.69%332.03K--90.64K
-General and administrative expense 1,081.17%2.2M1,329.78%2.95M331.91%1.44M748.87%2.82M2,208.60%2.09M126.77%186.42K182.34%206.12K286.90%333.42K28.69%332.03K--90.64K
Research and development costs 1,824.78%777.51K2,055.88%1.07M357.78%316.39K-70.05%193.58K-61.51%34.5K-78.64%40.4K-73.34%49.58K-61.95%69.11K-45.38%646.38K--89.63K
Depreciation amortization depletion --26.32K--26.04K--26.04K----------0--0--0--------
-Depreciation and amortization --26.32K--26.04K--26.04K----------0--0--0--------
Operating profit -1,225.21%-3.01M-1,480.74%-4.04M-342.82%-1.78M-207.85%-3.01M-1,079.95%-2.13M16.42%-226.81K1.27%-255.69K-50.30%-402.53K32.12%-978.42K-180.27K
Net non-operating interest income (expenses) 115.18%46.53K77.12%-88.26K97.31%-9.01K-6.21%-1.17M-34.31%-431.59K-9.30%-306.48K-41.64%-385.79K-46.63%-334.56K-59.55%-1.1M-321.33K
Non-operating interest income --55.51K------------------0----------------
Non-operating interest expense -97.07%8.98K-63.52%88.26K-95.28%9.01K40.29%739.1K--0124.45%306.48K88.26%241.92K126.20%190.7K356.50%526.83K--177.47K
Total other finance cost -------------25.00%431.59K---------0.00%143.86K0.00%143.86K0.00%575.45K--143.86K
Other net income (expenses) -769.93%-2.6M-261.22%-289.21K-1,582.18%-2.43M1,301.82%152.81K339.09%253.17K404.44%388.31K179.39K
Gain on sale of security ------------427.53%670.1K204.37%431.59K-26.66%120.26K1,301.82%152.81K339.09%253.17K-365.78%-204.6K---413.51K
Special income (charges) --------------0------------------592.9K----
-Less:Other special charges -----------------------------------592.9K----
Other non-operating income (expenses) ---------------3.27M---720.8K---2.55M----------------
Income before tax 0.15%-2.96M-745.18%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K
Income tax
Earnings from equity interest net of tax
Net income 0.15%-2.96M-745.18%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K
Net income continuous operations 0.15%-2.96M-745.18%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M---322.21K
Noncontrolling interests
Net income attributable to the company 0.15%-2.96M-745.19%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 0.15%-2.96M-745.19%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K
Diluted earnings per share 78.91%-0.31-723.55%-0.5-265.92%-0.22-121.27%-1.94-121.00%-0.3526-665.54%-1.4710.18%-0.060772.30%-0.0601-243.36%-0.8768-0.1596
Basic earnings per share 78.91%-0.31-723.55%-0.5-265.92%-0.22-121.27%-1.94-121.00%-0.3526-665.54%-1.4710.18%-0.060772.30%-0.0601-243.36%-0.8768-0.1596
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unaudited------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.